Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations

References

• Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6: 203–8
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2: 301–10
   PubMed Web of Science ®Google Scholar
• Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225–60
   PubMed Web of Science ®Google Scholar
• Moynagh PN. The NF-kappaB pathway. J Cell Sci 2005; 118: 4589–92
   PubMedGoogle Scholar
• Karban AS, Okazaki T, Panhuysen CI, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004; 13: 35–45
   PubMed Web of Science ®Google Scholar
• Ten RM, Paya CV, Israel N, et al. The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J 1992; 11: 195–203
   PubMed Web of Science ®Google Scholar
• Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978; 188: 824–8
   PubMed Web of Science ®Google Scholar
• Brostrom O, Lofberg R, Nordenvall B, Ost A, Hellers G. The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol 1987; 22: 1193–9
   PubMed Web of Science ®Google Scholar
• Solomon MJ, Schnitzler M. Cancer and inflammatory bowel disease: bias, epidemiology, surveillance, and treatment. World J Surg 1998; 22: 352–8
   PubMed Web of Science ®Google Scholar
• Parkin DM. International variation. Oncogene 2004; 23: 6329–40
   PubMed Web of Science ®Google Scholar
• Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 2004; 4: 519–27
   PubMed Web of Science ®Google Scholar
• Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene–environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 2001; 249: 477–93
   PubMed Web of Science ®Google Scholar
• Geddes M, Balzi D, Buiatti E, Khlat M, Parkin D. Cancer in Italian migrants. Cancer Causes Control 1991; 2: 133–40
   PubMed Web of Science ®Google Scholar
• Iscovich J, Howe GR. Cancer incidence patterns (1972–91) among migrants from the Soviet Union to Israel. Cancer Causes Control 1998; 9: 29–36
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Noh JJ. The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 2004; 14: 431–9
   PubMed Web of Science ®Google Scholar
• St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993; 118: 785–90
   PubMed Web of Science ®Google Scholar
• Hemminki K, Chen B. Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev 2004; 13: 1253–6
   PubMed Web of Science ®Google Scholar
• Lagerstedt Robinson K, Liu T, Vandrovcova J, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007; 99: 291–9
   PubMed Web of Science ®Google Scholar
• Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331: 1669–74
   PubMed Web of Science ®Google Scholar
• Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997; 53: 1253–61
   PubMed Web of Science ®Google Scholar
• Mayo MW, Baldwin AS. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000; 1470: M55–2
   PubMed Web of Science ®Google Scholar
• Craanen ME, Blok P, Offerhaus GJ, Tytgat GN. Recent developments in hereditary nonpolyposis colorectal cancer. Scand J Gastroenterol 1996; Suppl 218: 92–7
   Web of Science ®Google Scholar
• Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42: 216–2
   PubMed Web of Science ®Google Scholar
• Zhang YZ, Sheng JQ, Li SR, Zhang H. Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in the Chinese population. World J Gastroenterol 2005; 11: 1481–8
   PubMed Web of Science ®Google Scholar
• Borm ME, van Bodegraven AA, Mulder CJ, Kraal G, Bouma G. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis. Int J Immunogenet 2005; 32: 401–5
   PubMed Web of Science ®Google Scholar
• Mirza MM, Fisher SA, Onnie C, et al. No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 2005; 54: 1205–6
   PubMed Web of Science ®Google Scholar
• Oliver J, Gomez-Garcia M, Paco L, et al. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm Bowel Dis 2005; 11: 576–9
   PubMed Web of Science ®Google Scholar
• Lin SC, Liu CJ, Yeh WI, Lui MT, Chang KW, Chang CS. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring in older male areca (betel) chewers. Cancer Lett 2006; 243: 47–54
   PubMed Web of Science ®Google Scholar